Wilmington, Delaware, United States, March 26, 2017 -- The report “World Biopsy Devices Market - Opportunities and Forecasts 2022”, available on MarketIntelReports, estimates that the market will grow at a healthy CAGR of 5.5% till 2022.
Browse 32 Market Tables as well as 50 Figures which are spread through 158 Pages and an in-depth TOC on the “Biopsy Devices Market Forecast 2022” http://www.marketintelreports.com/report/allied0004/world-biopsy-devices-market--opportunities-and-forecasts-2014--2022
Scope & Regional Forecast of the Biopsy Devices Market
Biopsy Devices Market was valued at $1,621 million, and is expected to reach $2,399 million by 2022, supported by a CAGR of 5.5%. Biopsy is the surgical removal of tissue from an organ to determine the presence or extent of a disease, mostly cancerous and inflammatory conditions. This diagnostic procedure is generally performed by surgeons, radiologists, and interventional cardiologists, to confirm the presence of cancerous tissue. Biopsy procedures can be performed for almost any organ with the help of a specific biopsy device. Conventional biopsy devices can be complemented with advanced imaging technologies such as MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others to perform a biopsy procedure with accuracy and minimal invasiveness. These integrated procedures are important to perform biopsies in critical areas of the body such as the lungs, liver, and kidney.
Request Sample PDF Brochure @ http://www.marketintelreports.com/pdfdownload.php?id=allied0004
Increasing incidences of cancer such as breast, prostate, & lung, and rapid technological advancements have been stimulating the growth of the biopsy devices market. Moreover, increase in awareness for the diagnosis of chronic diseases such as breast cancer and lung cancer is also increasing the demand for integrated biopsy technologies such as MRI-guided biopsy. On the contrary, the use of advanced biopsy devices in developing countries is still restricted due to high cost, unawareness for the diagnosis of chronic diseases, and lack of technical expertise. However, companies are now concentrating on developing cost-effective biopsy devices, which would decrease the overall cost of biopsy procedures.
Inquiry before buying report @ http://www.marketintelreports.com/inquiry-before-buying.php?id=allied0004
Prominent Segmentations Involved in the Biopsy Devices Market
The Biopsy Devices Market can be broken down into various segmentations on the basis of -
- Type: Breast Biopsy Devices, Gastro Intestinal Biopsy Devices, Soft Tissue Biopsy Devices, Bronchial Biopsy Devices, Gynaecological Biopsy Devices, Robotic Guidance Systems and Others.
- Application: Breast Biopsy, Gastroenterology Biopsy, Prostate Biopsy, Liver biopsy, Lung biopsy, Kidney Biopsy, Gynaecological Biopsy and Others.
- Technology: MRIguided biopsy, StereotacticGuided Breast Biopsy, UltrasoundGuided Biopsy, CT guided biopsy and Others (positron emission mammography (PEM) imaging technology, Xray technology and RX technology).
- End Users: Diagnostic Centers and Hospitals.
- Geographical Location: North America, Europe, Asia-Pacific and LAMEA.
Some of the sample companies profiled in the Biopsy Devices Market report are as follows:
- Leica Biosystems (Devicor Medical products, inc.)
- Boston Scientific Corporation
- Cook Medical, Inc.
- Hologic, Inc.
- Mauna kea technologies.
- Becton Dickinson and Company (Carefusion Corp.)
- C. R. BARD, INC.
- Fujifilm Holdings Corp.
Why buy this report?
- Get a detailed picture of the Biopsy Devices Market.
- Pinpoint growth sectors and identify factors driving change.
- Understand the competitive environment, the market’s major players and leading brands.
- A five-year forecast method is used in order to assess how the market is predicted to develop.
Purchase Biopsy Devices Market Report @ http://www.marketintelreports.com/purchase.php?id=allied0004
About Us:
MarketIntelReports (MIR) aims to empower our clients to successfully manage and outperform in their business decisions. We do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.
MarketIntelReports currently has more than 150,000 plus titles and 100+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Media Contact:
Company Name: Market Intel Reports
Contact Person: Mayur S
Email: [email protected]
Phone: 1-302-261-5343
Address: 2712 Centerville Road, Suite 400
City: Wilmington
State: Delaware
Country: United States


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



